National Research Council Canada / Conseil national de recherches Canada
National Research Council Canada / Conseil national de recherches Canada Government of Canada
Go to main contentGo to section navigationGo to main navigation National Research Council Canada / Conseil national de recherches Canada
National Research Council Canada / Conseil national de recherches Canada
About Us
Corporate Overview
Mandate
Just the Facts
NRC Awards
NRC Corporate Publications
NRC Annual Report 2004-2005
NRC Annual Report 2003-2004
NRC Annual Report 2002-2003
NRC Report on Plans and Priorities
NRC Departmental Performance Report
NRC Strategy 2006-2011
Fact Sheets
Audit and Evaluation
  
Printable version Printable
version

Winnipeg - Life sciences and medical devices

View PDF version of this Manitoba Fact Sheet

NRC's Winnipeg-based biomedical technology cluster is acknowledged internationally as one of the fastest-growing concentrations of medical devices and life sciences industries in Canada. The 150 health-related companies and organizations associated with Manitoba's life sciences cluster generate sales of more than $440 million a year — a number that grows annually — and employ 4,200 people.

NRC Centre for the Commercialization of Biomedical Technology located in Winnipeg.
NRC Centre for the Commercialization of Biomedical Technology located in Winnipeg.

Impressive growth

Growth of the cluster has been steady since 1992, when NRC created its Institute for Biodiagnostics in a bid to advance Winnipeg's R&D capacity in medical devices and life sciences technology. At that time, the facility housed 25 NRC employees who conducted $2 million worth of research annually.Since then, NRC's commitment to biodiagnostics research has driven an impressive surge in the facility's R&D capacity; currently, 200 researchers, staff, and affiliated collaborators are engaged in about $15 million worth of R&D and technology transfer.

Moreover, the facility's revenues from collaborative research with private industry have, on an annual basis, grown substantially — an important measure of NRC's success as a cluster catalyst.

Successful technology transfer

Although the Winnipeg cluster is young, NRC's biodiagnostics researchers have transferred enough technology to private industry to create five separate technology spin-off companies — with an aggregate market value of over $200 million.The largest of these is IMRIS Inc. formed in 1997 to commercialize NRC-developed intra-operative MRI systems.

NRC scientists collaborate closely with medical researchers and clinicians to ensure rapid technology transfer from the lab to medical practice.The results are improved health-care facilities in Canadian communities and increased economic value for Canada as new technologies become viable products in the global marketplace.

The IMRIS Magnetic resonance imaging system.
The IMRIS Magnetic resonance imaging system.

Commercialization a priority

In October 2005,NRC stepped up its contribution to Winnipeg's growing technology cluster by opening the NRC Centre for Commercialization of Biomedical Technology. The Centre is a key element of NRC's clustering strategy and considered by many as a model for public-private sector partnerships.

The Centre provides research facilities and innovation services for up to 40 companies and technology organizations — helping them bring pioneering biomedical innovations to market. It also helps link emerging medical imaging and medical device companies to expertise across Canada and around the globe.

Services include support for industrial research as well as access to up-to-date science and technology information and competitive technology intelligence. A suite of business-related services, including business planning,marketing strategy support, and intellectual property protection services, is provided by Biomedical Commercialization Canada, a national not-for-profit organization in partnership with the NRC and the Manitoba government.

 
 
CLUSTER FACTS AT A GLANCE
 
 

Manitoba houses more than 150 health-related companies that generate sales of more than $440 million a year.

 
 

Manitoba jobs in life sciences grew by 960% between 1989 and 2004.

 
 

NRC's biodiagnostics R&D facility has a $30 million-a-year impact on the Winnipeg economy

 
 

Biodiagnostics companies spun-off from NRC are worth over $200 million.

 
 

Transforming technology into business

NRC offers strategic services to businesses that are looking to take their innovations to market — easing the transition from small start-up company to bona fide industrial presence.

NRC researcher examining specimen through inverted miscroscope.
NRC researcher examining specimen through inverted miscroscope.

Assisting with industrial research

The NRC Industrial Research Assistance Program — aimed specifically at helping small- and medium-sized businesses develop technologies for market — has injected nearly $70 million into small- and medium-sized Manitoba businesses since 2000. In 2005 alone, the program contributed $15 million toward commercializing groundbreaking technologies and ingenious, lucrative business ideas.

Best available science and technology literature

NRC is a world leader in electronic publishing, and Canada's largest and best resource for scientific, technical & medical information. NRC's science and technology information services are integral to Manitoba's life sciences and medical devices cluster, providing growing companies with the vital information they need to produce cuttingedge innovations.

"Over the years we have also had an opportunity to deal with other technical and business libraries. The NRC-CISTI team has provided more relevant and timely technical and business information than other information providers. In part this comes from a willingness and ability to participate in some of the client meetings up front, but more often it is the open dialogue and understanding of the goals of competitive intelligence. They are often able to go outside the parameters of the original question and make connections to all possible information that could be important to a company's current needs." – Mavis McRae, Prairie Centre for Business Intelligence

 
 
COMMUNITY ENGAGEMENT
 
 

1992 — NRC opens Winnipeg-based biodiagnostics R&D lab with staff of 25

 
 

1997 — NRC spins off IMRIS Inc., formed to commercialize MRI technology

 
 

2001 — Collaborative research income tops $1 million at biodiagnostics research facility

 
 

2002 — NRC announces plans for the NRC Centre for Commercialization of Biotechnology (NRC-CCBT)

 
 

2003 — Province commits $2 million to NRC-CCBT

 
 

2004 — Agreement with Biomedical Commercialization Canada to provide incubation services to companies in the NRC-CCBT

 
 

2004 — NRC launches Medical Technology Watch Canada newsletter

 
 

2005 — NRC-CCBT opens its doors

 
 
Examining brain images taken by magnetic resonance imaging system.
Examining brain images taken by magnetic resonance imaging system.

"This investment (in NRC-CCBT) demonstrates our ongoing efforts to make Manitoba a national centre for medical innovation... "

Gary Doer, Premier of Manitoba

Technical expertise

NRC in Winnipeg has had many research collaborations with local, national, and international companies in the biomedical sector. These companies seek NRC's expertise to solve R&D challenges. NRC's Winnipeg research facility employs highly trained personnel in diverse fields such as physics, mathematics, medicine, chemistry, biology and engineering, which results in a multidisciplinary approach to biomedical problem solving.

Leading-edge newsletter

Side view of MRISince 2004, NRC has produced a leading-edge newsletter, Medical Technology Watch Canada, which is distributed internationally. The publication is designed to deliver timely, relevant information about the medical technology industry in Canada to partners in the cluster, and beyond. As a community-building vehicle, it provides Canadian companies, researchers and investors with unique insights on key research and innovation being done by Canadian R&D organizations and SMEs.

Increasing collaboration

Stakeholders of the Winnipeg cluster have come together around the concept of a 'BioMed City', visualized to be a designated development zone, near NRC, where laboratories and scientists could provide synergies for new research, training, product development, commercialization and company start-ups. This important development underlines NRC's success at sparking collaboration among the cluster's stakeholder groups.

 
 
NRC'S CLUSTER PARTNERS
 
 

University of Manitoba

 
 

University of Winnipeg

 
 

National Microbiology Laboratory and Canadian Science Centre for Human and Animal Health (Public Health Agency of Canada)

 
 

St. Boniface General Hospital and Research Centre

 
 

Health Sciences Centre/Children's Hospital

 
 

Health Care Products Association of Manitoba

 
 

Red River College of Applied Arts, Science and Technology

 
 
Operating room.
Operating room.

"Since 1990 when the Health Care Products Association of Manitoba (HCPAM) was first incorporated with a membership of four companies, to 2005 with a membership of 80 companies,we have experienced first hand the dynamic growth of the industry in Manitoba. NRC is a major player providing industry with access to scientific expertise and business development skills that are critical to the growth of the life sciences cluster in the province."

Marguerite Laramee, Executive Director,HCPAM


http://ibd.nrc-cnrc.gc.ca



National Research Council Canada
1200 Montreal Road
Ottawa, ON K1A 0R6
Tel.: (613) 993-9101
www.nrc-cnrc.gc.ca

NRC Institute for Biodiagnostics
435 Ellice Avenue
Winnipeg, MB R3B 1Y6

Dr. Ian Smith
Director General
Tel.: (204) 983-7526
ian.smithatnrc-cnrc.gc.ca

NRC Centre for the Commercialization of Biomedical Technology
445 Ellice Avenue
Winnipeg, MB R3B 3P5

Paul Wiebe
Director, Business Development & Community Outreach
Tel.: (204) 984-6223
paul.wiebeatnrc-cnrc.gc.ca


Date Modified: 2006-03-30
Top of page